Alpha Diagnostic International, Inc. Human Monocarboxylate Transporter 6 (MCT6) Control/blocking peptide # 1 MCT65-P

Human Monocarboxylate Transporter 6 (MCT6) Control/blocking peptide # 1 General Information MCT6/SLC16A5 (human 505-aa, ch 17q25.3) is highly expressed in kidney and placenta. According to new nomenclature, the old MCT5 has now been reclassified as MCT6. This antibody has previously been listed as MCT52-S. Please consult our web site and Hal SugApplications Control or blocking peptides are recommended for ELISA plate coating for direct ELISA testing of antibodies or competitive ELISA, and antibody blocking or neutralization. SpeciesReactivity Human Form Antigen/blocking Peptide Antigen 18-aa peptide from (Gene Accession #Q6P1X3) human MCT6 (1); Designation (#MCT65-P, control/blocking peptide) conjugated to KLH; Epitope location~ C-terminal, Cytoplasmic domain SpCrossreactivity Human MCT65-P sequence has no significant sequence homology with other MCTs. It is 70% conserved in mouse and 65% in rat MCT6. Antibody crossreactivity in various species has not been studied For research use only, not for diagnostic or therapeutic use.